Full Text
PCN3 ECONOMIC IMPACT OF SECOND- ANDTHIRD-LINE ERLOTINIB TREATMENT OF NON SMALL-CELL LUNG CANCER-A FRENCH OBSERVATIONAL STUDY

Abstract

Authors

C Chouaid A Vergnenegre A Moser C Coudray-Omnes

Back to Volume 10, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×